Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
REPORT DATE
31-03-2008
REPORT TYPE
Email:5f. WORK UNIT NUMBER
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBERChildren's Hospital of Pittsburgh Pittsburgh, PA 15213
SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR'S ACRONYM(S)
U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012
SPONSOR/MONITOR'S REPORT NUMBER(S)
DISTRIBUTION / AVAILABILITY STATEMENTApproved for Public Release; Distribution Unlimited
SUPPLEMENTARY NOTES
ABSTRACTSee Next Page(s).
SUBJECT TERMSNone listed. Investigator: Huard, Johnny -7 -
INTRODUCTIONResearchers continue to investigate whether gene transfer to skeletal muscle can enable both the production of proteins that might be therapeutic for muscle disorders and the systemic delivery of non-muscle proteins.Although the engineering of new mutant vectors has reduced the problems associated with viral cytotoxicity and immune rejection after gene transfer, the inability of most viral vectors to efficiently transduce mature muscle fibers continues to impede gene transfer to skeletal muscle. Results from our laboratory and others have shown that adenovirus (AV), retrovirus (RSV), and herpes simplex virus (HSV) vectors all can transduce neonatal mouse muscle efficiently; however, the muscle becomes largely resistant to viral transduction within a few days after birth. We have identified the primary barriers of viral gene transfer to mature skeletal muscle and have investigated methods by which to overcome these barriers. Among such approaches, the ex vivo technique constitutes the most efficient method for delivery of viral vectors (AV, RSV, and HSV) to mature skeletal muscle. In this project, we will investigate ex vivo gene transfer to the dystrophic skeletal muscle of mature mdx mice (which model Duchenne muscular dystrophy) by using isogenic muscle-derived cells (satellite cells or muscle-derived stem cells [MDSCs]) and retroviral vectors encoding for a functional human mini-dystrophin gene. We first will compare these 2 populations of muscle-derived cells-satellite cells and MDSCs-to identify which ...